Concepts (69)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Emergency Service, Hospital | 6 | 2021 | 711 | 1.580 |
Why?
|
Atrial Fibrillation | 3 | 2021 | 249 | 0.890 |
Why?
|
Benzodiazepines | 1 | 2021 | 130 | 0.710 |
Why?
|
Status Epilepticus | 1 | 2021 | 74 | 0.700 |
Why?
|
Anticonvulsants | 1 | 2021 | 223 | 0.660 |
Why?
|
Practice Patterns, Physicians' | 1 | 2021 | 504 | 0.540 |
Why?
|
Fluid Therapy | 1 | 2015 | 59 | 0.500 |
Why?
|
Clinical Protocols | 1 | 2015 | 172 | 0.480 |
Why?
|
Triage | 1 | 2015 | 109 | 0.470 |
Why?
|
Sepsis | 1 | 2015 | 233 | 0.420 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2021 | 98 | 0.360 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 1026 | 0.350 |
Why?
|
Calcium Channel Blockers | 2 | 2020 | 138 | 0.340 |
Why?
|
Retrospective Studies | 7 | 2021 | 7277 | 0.230 |
Why?
|
Procainamide | 1 | 2021 | 12 | 0.190 |
Why?
|
Doxycycline | 1 | 2021 | 49 | 0.190 |
Why?
|
Sodium Channel Blockers | 1 | 2020 | 23 | 0.180 |
Why?
|
Diltiazem | 1 | 2019 | 26 | 0.170 |
Why?
|
Cyclonic Storms | 1 | 2020 | 59 | 0.170 |
Why?
|
Factor Xa Inhibitors | 1 | 2019 | 43 | 0.170 |
Why?
|
Anti-Infective Agents | 1 | 2021 | 166 | 0.170 |
Why?
|
Time Factors | 2 | 2019 | 4655 | 0.170 |
Why?
|
Electric Countershock | 1 | 2020 | 130 | 0.170 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 80 | 0.170 |
Why?
|
Medication Errors | 1 | 2020 | 116 | 0.160 |
Why?
|
Drug Prescriptions | 1 | 2020 | 135 | 0.160 |
Why?
|
Accidental Falls | 1 | 2019 | 84 | 0.160 |
Why?
|
Patient Discharge | 1 | 2020 | 294 | 0.150 |
Why?
|
Electrocardiography | 1 | 2020 | 601 | 0.150 |
Why?
|
Body Weight | 1 | 2019 | 554 | 0.150 |
Why?
|
Anticoagulants | 1 | 2020 | 356 | 0.150 |
Why?
|
Emergency Medical Services | 1 | 2020 | 225 | 0.140 |
Why?
|
Humans | 9 | 2021 | 68618 | 0.120 |
Why?
|
Middle Aged | 4 | 2021 | 21147 | 0.120 |
Why?
|
Genomic Imprinting | 1 | 2011 | 10 | 0.100 |
Why?
|
Electronic Health Records | 1 | 2015 | 374 | 0.100 |
Why?
|
Epistasis, Genetic | 1 | 2011 | 32 | 0.100 |
Why?
|
Telemedicine | 1 | 2020 | 700 | 0.100 |
Why?
|
Male | 5 | 2021 | 37321 | 0.090 |
Why?
|
Female | 5 | 2021 | 38074 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2011 | 241 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 163 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2011 | 334 | 0.070 |
Why?
|
Antibiotic Prophylaxis | 1 | 2021 | 62 | 0.050 |
Why?
|
Infusions, Intravenous | 1 | 2021 | 334 | 0.050 |
Why?
|
Emergency Shelter | 1 | 2020 | 4 | 0.040 |
Why?
|
Administration, Intravenous | 1 | 2019 | 89 | 0.040 |
Why?
|
Geriatrics | 1 | 2019 | 69 | 0.040 |
Why?
|
Disaster Planning | 1 | 2020 | 105 | 0.040 |
Why?
|
Heart Rate | 1 | 2019 | 568 | 0.040 |
Why?
|
Incidence | 1 | 2020 | 1603 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 1745 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2019 | 1553 | 0.030 |
Why?
|
Aged | 2 | 2019 | 14862 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 3705 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 2011 | 23 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 181 | 0.020 |
Why?
|
Adipocytes | 1 | 2011 | 88 | 0.020 |
Why?
|
Fatty Liver | 1 | 2011 | 97 | 0.020 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2011 | 87 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2019 | 4848 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 235 | 0.020 |
Why?
|
Hepatocytes | 1 | 2011 | 205 | 0.020 |
Why?
|
Cytokines | 1 | 2011 | 866 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 2791 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2011 | 2550 | 0.010 |
Why?
|
Adult | 1 | 2021 | 21403 | 0.010 |
Why?
|
Mice | 1 | 2011 | 8474 | 0.010 |
Why?
|
Animals | 1 | 2011 | 20881 | 0.010 |
Why?
|